Y-mAbs Therapeutics Inc.

6.18
-0.01 (-0.16%)
At close: Jan 22, 2025, 3:59 PM
6.19
0.08%
After-hours Jan 22, 2025, 04:41 PM EST

Y-mAbs Therapeutics Inc. Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for YMAB stock have an median target of 23, with a low estimate of 17 and a high estimate of 26. The median target predicts an increase of 272.17% from the current stock price of 6.18.

Analyst Consensus: Buy
Target Low Average Median High
Price $17 $22.22 $23 $26
Change 175.08% 259.55% 272.17% 320.71%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Y-mA... Unlock content with Pro Subscription

Updated Jan 13, 2025

Rating Jul 24Aug 24Sep 24Nov 24Dec 24Jan 25
Strong Buy 000000
Buy 142221
Hold 000000
Sell 010000
Strong Sell 000000
Total 1 5 2 2 2 1

Financial Forecast this Year

Revenue This Year
88.30M
from 84.82M
Increased by 4.1%
Revenue Next Year
104.55M
from 88.30M
Increased by 18.4%
EPS This Year
-0.63
from -0.49
Increased by -28.6%
EPS Next Year
-0.58
from -0.63
Increased by 7.9%